Delivery Order SPE2DB24D1007-SPE2DB25FB5QJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,199.18 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing federal contract portfolio with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.24 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Corlanor 5 mg tablets (60-count packaging) with a ceiling value of $1,399.38. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by August 5, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Corlanor 5 mg tablets (60-count unit) valued at $4,410.48 under a firm fixed-price contract type. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, valued at $3,636.97. The award, made on August 26, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $3,265.42 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units) under a firm fixed-price contract valued at $1,923.54. The order was competitively awarded without set-aside designation and is scheduled for completion by August 26, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Corlanor 5 mg tablets (60-count units) with a ceiling value of $14,988.19. This firm fixed-price delivery order, which carries an ultimate completion date of August 21, 2025, represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Corlanor (ivabradine) is a cardiac medication used to treat heart...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg with a ceiling value of $1,955.30. This firm fixed price, non-set-aside contract was awarded on September 4, 2025, with an ultimate completion date of September 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a typical transaction under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,615.05 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count units) on August 5, 2025, with completion expected by August 6, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FB5QJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) valued at $2,313.94. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The Corlanor order represents a specific fulfillment within this expansive contract vehicle that supports the Defense Health Agency and other federal healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/18/25 |